Home/Filings/4/0001209191-21-004840
4//SEC Filing

Magnani John L. 4

Accession 0001209191-21-004840

CIK 0001253689other

Filed

Jan 21, 7:00 PM ET

Accepted

Jan 22, 4:03 PM ET

Size

8.4 KB

Accession

0001209191-21-004840

Insider Transaction Report

Form 4
Period: 2021-01-20
Magnani John L.
DirectorVP of Research, CSO
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-01-20+69,00069,000 total
    Exercise: $3.81Exp: 2031-01-19Common Stock (69,000 underlying)
  • Award

    Common Stock

    2021-01-20+34,500324,260 total
Holdings
  • Common Stock

    (indirect: By GlycoTech Corporation)
    4,845
Footnotes (4)
  • [F1]The security represents restricted stock units granted to the reporting person. Each restricted stock unit represents a contingent right to receive one share of common stock of the Issuer.
  • [F2]25% of these restricted stock units vest on each of January 20, 2022, 2023, 2024 and 2025, subject to the reporting person's continuous service as of each such vesting date.
  • [F3]These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.
  • [F4]25% of the shares underlying this option vest on January 20, 2022 and the balance of the shares vest in a series of 36 successive equal monthly installments thereafter, subject to the reporting person's continuous service as of each such vesting date.

Issuer

GLYCOMIMETICS INC

CIK 0001253689

Entity typeother

Related Parties

1
  • filerCIK 0001589713

Filing Metadata

Form type
4
Filed
Jan 21, 7:00 PM ET
Accepted
Jan 22, 4:03 PM ET
Size
8.4 KB